Abstract
Epithelial-to-mesenchymal transitions (EMT) are strongly implicated in cancer dissemination. Intermediate states, arising from inter-conversion between epithelial (E) and mesenchymal (M) states, are characterized by phenotypic heterogeneity combining E and M features and increased plasticity. Hybrid EMT states are highly relevant in metastatic contexts, but have been largely neglected, partially due to the lack of physiologically-relevant 3D platforms to study them. Here we propose a new in vitro model, combining mammary E cells with a bioengineered 3D matrix, to explore phenotypic and functional properties of cells in transition between E and M states. Optimized alginate-based 3D matrices provided adequate 3D microenvironments, where normal epithelial morphogenesis was recapitulated, with formation of acini-like structures, similar to those found in native mammary tissue. TGFβ1-driven EMT in 3D could be successfully promoted, generating M-like cells. TGFβ1 removal resulted in phenotypic switching to an intermediate state (RE cells), a hybrid cell population expressing both E and M markers at gene/protein levels. RE cells exhibited increased proliferative/clonogenic activity, as compared to M cells, being able to form large colonies containing cells with front-back polarity, suggesting a more aggressive phenotype. Our 3D model provides a powerful tool to investigate the role of the microenvironment on metastable EMT stages.
Similar content being viewed by others
Introduction
Epithelial–to-mesenchymal transition (EMT) is a central process occurring during embryogenesis and wound healing, being also highly implicated in cancer progression1,2,3. During EMT, epithelial (E) cells progressively lose polarity and cell-cell contacts acquiring a mesenchymal (M) phenotype with increased migratory and invasive potential3,4. EMT confers plasticity to cells, contributing to cell dispersion during development and cancer dissemination1,2. In epithelial cancers, invading cells display EMT-like features such as a mesenchymal phenotype associated with expression of vimentin (M marker), and loss of epithelial E-cadherin expression, and/or detachment and movement towards the stroma4. These cells may undergo the reverse process, mesenchymal-to-epithelial transition (MET), in order to allow growth and colonization at secondary sites, forming metastasis5.
Importantly, tumor cells may undergo partial EMT with transitory acquisition of mesenchymal characteristics while retaining epithelial features. These intermediate states, so-called metastable phenotypes, are characterized by phenotypic heterogeneity and cellular plasticity and likely represent the most aggressive clones in a tumor6,7,8. In addition, when cancer cells successfully establish metastasis at secondary sites, they re-acquire E markers while maintaining aggressive tumor features6,7,9. Yet, the study of EMT intermediate stages has been limited by the lack of specific phenotypic markers that hampers identification of these cells in vivo6,10, and by the lack of reliable models to examine inter-conversion between E and M states in vitro8,11,12.
To explore the phenotypic and transcriptional switching of cells during EMT, we have previously established an in vitro 2D model of transforming growth factor-β1 (TGFβ1)-induced EMT and its reversion12,13. TGFβ1 supply to the near-normal E cell line EpH4 efficiently generated M-like cells, and its removal resulted in the re-acquisition of an epithelial-like phenotype. The later cellular state, that we named reversed epithelia (RE cells), is characterized by the co-existence of several and heterogeneous cellular populations with regard to the expression of E-cadherin (E marker) or fibronectin (M marker)13. In our 2D model, we also demonstrated that RE cells, generated through MET, together with heterogeneity display increased mamosphere formation efficiency and in vivo tumourigenesis ability13. RE cells, unlike E and M, possibly reproduce tumor heterogeneity often described in primary and metastatic clinical samples8,11. Still, traditional 2D models are reductionist, since they fail to recapitulate key architectural features of native tissues, namely in what concerns the impact of the extracellular matrix mechanical and biochemical properties14. The paradigm shift from 2D to 3D culture is underway and progressing rapidly, being currently recognized that adding the 3rd dimension to a cell’s environment creates significant differences in cellular characteristics and function15. M Bissel’s team elegantly demonstrated the relevance of using 3D systems to investigate cancer mechanisms, by creating a prototypical model of the mammary gland acinus, where TGFβ1-induced EMT occurred16. 3D models where cells are completely surrounded by a supportive 3D matrix, i.e. hydrogel-based entrapment systems, are the most relevant systems for modulating cell-matrix interactions17,18,19. Extracellular matrix (ECM)-derived protein gels such as collagen or MatrigelTM are commonly used, but generally present poorly tunable biochemical/biomechanical properties, high batch-to-batch variability and intrinsic bioactivity, which makes it very difficult to compare results between different Laboratories, and even between different experiments18,20. More recently, biomaterial-based platforms, traditionally associated with tissue engineering approaches, have been translated into cancer research creating improved models to study tumor biology, where matrix bioactivity and mechanical properties can be more easily controlled18,19,21,22.
In this work, our 2D model evolved towards a new 3D in vitro model, by combining the inducible epithelial cell line (EpH4)12,13 and a bioengineered ECM-like matrix with independently tunable properties, to explore the inter-conversion between E and M states during EMT and its reversion (MET). The selected 3D matrix, composed of an optimized soft alginate hydrogel functionalized with cell adhesive RGD peptides23,24, supported epithelial morphogenesis, promoting the formation of acinar-like structures similar to those present in mammary tissue, and allowed TGFβ1-induced generation of cells with mesenchymal-like and intermediate phenotypes, providing a useful tool to unravel cellular alterations associated with EMT/MET.
Results
3D culture in soft RGD-alginate matrices preserves the epithelial phenotype of normal mammary EpH4 cells and promotes epithelial morphogenesis
Soft alginate hydrogels functionalized with cell-adhesion RGD peptides were used in this study to simulate the 3D microenvironment of normal mammary tissue. To determine the best culture conditions for EpH4 cells, these were cultured along 14 days in alginate 3D matrices (i) with and without RGD, (ii) with different stiffness (G’ ≈ 200 Pa with 1 wt.% alginate, G’ ≈ 3000 Pa with 2 wt.% alginate) and (iii) at different cell densities (1 × 106, 5 × 106 and 10 × 106 cells/mL). From these preliminary assays (some data not shown), softer alginate hydrogels with 200 μM RGD and a cell density of 5 × 106 cells/mL showed to be the best conditions for culturing EpH4 cells in 3D, namely by enabling the formation of larger multicellular spheroids with higher cell viability (Fig. 1a–c). The presence of tethered cell-adhesion RGD ligands in the matrix, at a density of 200 μM, similar to that found in common ECM-derived biological matrices25, was essential, leading also to higher cell metabolic activity (Fig. 1d). The stiffness of the softer hydrogels (G’ ≈ 200 Pa) was comparable to that of normal mammary tissue26,27,28, and remained essentially unchanged along the culture period (Fig. 1e), as demonstrated by rheological analysis of cell-laden 3D matrices.
Immunodetection of proliferative cells (Ki67 proliferation marker) showed that EpH4, which were initially distributed as single cells within the 3D matrices, were able to proliferate, generating spheroids. At day 1, Ki-67 staining depicted proliferation in individual cells, but at days 7 and 14 proliferative cells were essentially restricted to spheroids (Fig. 2a). The analysis of mitochondrial metabolic activity (Fig. 2b) showed a significant increase along the first week of culture, suggesting that cells were actively proliferating, while from day 7 to day 14 no significant differences were observed. As time progressed, spheroids size increased reaching an average diameter of around 30 μm by day 14 (Fig. 2c,d).
Normal murine mammary epithelial EpH4 cells that typically assume a polygonal or cuboidal shape in 2D monolayer culture, with forced, non-physiological cell polarization (Fig. 3a), assembled into large spheroids when cultured in soft RGD-alginate 3D matrices (Fig. 3b). This 3D arrangement mimics the typical cell/matrix organization found in normal mammary tissue (Fig. 3c), being histologically identical. Structures formed by EpH4 cells in 3D were classified according to five categories, as proposed in29, namely: (I) immature with few cells, (II) spherical with a filled lumen, (III) spherical with a hollow lumen, (IV) non-spherical but organized, or (V) non-spherical and disorganized. After 12 days of culture, only structure classes I-III were observed. Around 20% of those structures already presented a cleared lumen (Supplementary Fig. S1), resembling mammary acini, the basic anatomical units of the mammary gland.
F-actin and E-cadherin staining of EpH4-laden hydrogels, also revealed the formation of uniform spheroids after 10–14 days in 3D culture (Fig. 3d–g). Lumenized structures (Fig. 3e,f) showed peripheral nuclear alignment and apical-basal polarity maintained by the precise arrangement of actin filaments (Fig. 3e)30, namely at interior luminal surface and at cell-cell junctions, and stained positively for functional E-cadherin (Fig. 3f), a prototypical epithelial marker, which was localized at the cell membrane, stabilizing cell-cell contacts within spheroids. Furthermore, lumenized spheroids showed segregation of polarity markers (Fig. 3h–j): basolateral β-catenin was nearly absent on the apical side, whereas zonula occludens-1 (ZO-1) was notably present, although with some persistence at the basal side. Importantly, cells were able to assemble a laminin-rich layer around spheroids, at the basal edge (Fig. 3k).
By qRT-PCR, we assessed the mRNA expression of epithelial markers, CDH1 (encoding E-cadherin) and Ocln (encoding Occludin); mesenchymal marker CDH2 (encoding N-cadherin); and transcription factor Zeb2, a well-known EMT inducer (Fig. 4a). None of the assessed markers were significantly altered across time, suggesting that 3D culture within RGD-alginate hydrogels preserves EpH4 cells epithelial phenotype and supports normal epithelial morphogenesis.
TGFβ1 induces EMT in normal mammary epithelial EpH4 cells cultured under 3D conditions and its removal generates cells with intermediate phenotype
Having established that 3D culture within RGD-alginate hydrogels did not promote EMT per se; we next induced EMT by exposure to soluble TGFβ1 (Fig. 4b)12,13. Media supplementation with 16 ng/mL TGFβ1 (Fig. 5a) generated M-like cells from E cells, after 7 days in culture. This concentration had to be optimized relatively to our previous 2D model, where a TGFβ1 concentration of 8 ng/mL had been used. As a control, we used EpH4 cells cultured for 7 days in standard culture media (E cells). As observed by immunofluorescence (Fig. 5a), M cells presented decreased E-cadherin (E-cad) expression (as compared to E cells), and delocalization from the cell membrane to the cytoplasm, suggesting impaired functionality as cell-cell adhesion molecule. M cells also expressed typical mesenchymal markers, namely fibronectin (FN) and vimentin (Vim). Importantly, M cells not only expressed intracellular fibronectin but also assembled pericellular fibronectin within multicellular aggregates (Fig. 5a).
Removal of TGFβ1 from the culture medium for an additional week, led to partial phenotypic reversion from a mesenchymal-like to an epithelial-like state (RE cells), in which E-cad expression at cell membrane was recovered, while expression of M markers (FN and Vim) was still present (Fig. 5a). To better examine whether the observed phenotypic alterations were due to EMT and its reversion, we next analyzed mRNA expression by qRT-PCR (Fig. 5b) of several relevant markers. The mRNA expression of CDH1 (E marker) remained unchanged across the experiment, while Ocln expression (E marker) was only significantly increased in RE cells (p = 0.05). Expression of the mesenchymal marker CDH2 and the EMT inducer Zeb2, was significantly increased upon EMT induction (M cells) (p = 0.0286 for CDH2, p = 0.0286 for Zeb2), and remained elevated in RE cells. Expression of Mgat3, an epithelial-associated marker12,31, was significantly decreased in M cells (p = 0.0286) and remained at low levels in RE cells (ca. 2-fold). Finally, mRNA expression of Id2 (inhibitor of differentiation 2), which is considered as a key negative regulator of TGFβ1–induced EMT in epithelial cells32, was significantly decreased in M cells, as compared to E cells (p = 0.0286), slightly recovering in RE cells. Overall, expression of EMT markers in E, M and RE cells, at protein and gene levels, point to the occurrence of TGFβ1–induced EMT and partial reversion to an epithelial-like phenotype in 3D, as observed in our 2D model12,13.
Inter-conversion between epithelial and mesenchymal phenotypes during TGFβ1–induced EMT and its reversion in 3D
To better understand the inter-conversion between epithelial and mesenchymal states in our 3D model, we further characterized the behavior of E, M and RE cells at different levels. E cells presented the highest levels of mitochondrial metabolic activity (Fig. 6a) and total dsDNA content (Fig. 6b), indicating a higher proliferative activity. M cells showed a significant decrease (ca. 2-fold) of both parameters (p = 0.002 and p < 0.0001, respectively), supporting growth-arrest promoted by TGFβ1. Finally, RE cells presented intermediate values, implying that EMT reversion allow cells to partially recover their proliferative activity (p = 0.0038 for total dsDNA content). Analysis of multicellular spheroid formation (Fig. 6c–e), largely related with clonal cell growth, provided further insights into E, M and RE cells proliferation patterns. E cells formed higher numbers of spheroids, with higher average diameter, as compared to M and RE cells. In contrast, M cells formed significantly less and smaller spheroids, while RE cells generated an intermediate number of spheroids, but with a large diameter variation. Noteworthy, the largest spheroids observed across the 3D model occurred in RE cells, with diameters reaching up to 100 μm.
E, M and RE cells express different levels of MMPs activity and display different invasive behaviors
Cells undergoing EMT are known to acquire a migratory phenotype and increased invasion capacity, features also seen in tumor cells that invade and metastasize. Expression of matrix metalloproteinases (MMP) activity is known to play a key role in these processes, namely in ECM degradation33,34. Here, we quantified the secretion of MMP2 and MMP9 (Fig. 7a) and our results show that both were significantly increased in M cells (as compared to E cells, p = 0.05). Secretion of both MMPs was significantly decreased in RE cells, when compared to M cells (p = 0.05).
To evaluate their invasion potential, E, M and RE cells were recovered from RGD-alginate 3D matrices and entrapped in MatrigelTM for 7 days. Each of the three states displayed unique morphological features. Organized spheroids with lumen, suggestive of a non-invasive phenotype (Fig. 7b), were only detected in E cells, which also presented the highest metabolic activity (Fig. 7c, p = 0.05). In both M and RE cell cultures, multicellular aggregates with a star-like appearance and containing cells with spindle-like morphology were detected (Fig. 7b), which have been associated with invasive phenotypes35,36. The size of such structures was much larger in RE cells (as compared to M cells), which concomitantly presented higher metabolic activity (Fig. 7c), suggesting higher proliferative activity. Altogether, these results show that RE cells generated in our 3D model, present an intermediate phenotype, combining mesenchymal and epithelial features.
Discussion
In this report, we describe a new 3D in vitro model, combining an inducible epithelial cell line (EpH4)12,37 with a bioengineered ECM-like matrix, to explore transitions between epithelial and mesenchymal phenotypes. Current interest in these processes stems from their well-documented involvement in cancer dissemination5,38. Different reports experimentally support the idea that EMT reversion is key for successful colonization and metastasis of different types of cancers39,40. Yet, while EMT has been largely studied by examining “pure” epithelial or mesenchymal states, transient (metastable) phenotypes, still remain poorly understood, especially because there are quite difficult to capture in vivo6,10. By creating greater similarity with in vivo scenarios, as compared to monolayer 2D models, 3D models of EMT and its reversion are likely to generate instrumental tools to mechanistically understand these intermediate phenotypes. These models may allow the identification of novel players with relevance in cancer progression and therapy.
In this study, an alginate-based hydrogel matrix was used to recreate a suitable 3D microenvironment for culturing EpH4 cells, capable of mimicking the stromal component of mammary tissue. Alginate is a natural polymer able to form hydrogel matrices that are essentially bio-inert, in the sense that they do not elicit specific cell-matrix interactions. However, alginate chains can be covalently modified with bioactive moieties, namely with peptides containing the amino acid sequence arginine-glycine-aspartic acid (Arg-Gly-Asp, RGD) to promote integrin-mediated cell adhesion and cell-matrix crosstalk, as already demonstrated for other types of hydrogels29. Moreover, alginate concentration and molecular weight can be easily altered to modulate the viscoelastic properties and degradation rate of the resulting hydrogels41. Here, to provide physiologically-relevant biochemical and biomechanical cues, we fine-tuned the properties of alginate hydrogels to attain a density of cell-adhesion ligands (200 μM)25 similar to that present in common ECM-derived biological matrices and viscoelastic properties (G’ ≈ 200 Pa) comparable to that of normal breast tissue and mammary gland26,27,28. We also monitored the evolution of hydrogel stiffness along time, to guarantee that it would remain unchanged throughout the culture period, as several studies have demonstrated that soft matrices are protective against EMT, whereas stiffer matrices may promote EMT inducing malignant phenotypes in normal mammary epithelial cells42,43.
In optimized RGD-alginate 3D matrices, single EpH4 cells were able to proliferate, forming spheroids by clonal-growth as suggested by the patterning of Ki67 staining. This was further demonstrated by pre-labeling EpH4 cells with fluorescent dyes of different colors, and by observing the formation of single-color spheroids after same days in culture (Fig. S2). We also observed, to a lesser extent, multi-color spheroids likely derived from early aggregation of labeled single cells in close proximity, or some kind of inter-cellular dye exchange resulting in dual fluorescence labeling44 (Fig. S2). Along the time of culture, these multicellular structures maturated into spheroids with a hollow central lumen, which recapitulate mammary acini strcuturee. They presented typical features, such as growth arrest, apico-basal organization with segregation of polarization markers and deposition of an endogenous laminin-rich matrix layer at the basal edge, mimicking the native basal lamina. Noteworthy, correct cell polarization is a clear requirement of epithelial cells models, since polarity influences intracellular signal trafficking, gene expression and phenotype45. Altogether, these results validate our model in its capacity to efficiently recapitulate normal epithelial morphogenesis, as already reported using both natural and synthetic, yet more complex, 3D matrices16,22,46. The maintenance of mRNA expression levels of typical E markers (CDH1, Ocln), with no up-regulation in expression of M markers (CDH2) and EMT inducers (Zeb2), demonstrated that 3D culture within soft RGD-alginate matrices does not induce EMT per se47,48. Overall, by promoting ex vivo organotypic cellular organization under controlled experimental conditions, our model provides a relevant platform for mimicking the microenvironment of epithelial tumors, since epithelial cells grown as monolayers on plastic surfaces bear little to no resemblance to their in vivo counterparts45.
After establishing a reliable 3D platform for normal epithelial morphogenesis, we then demonstrated that EMT could be successfully promoted upon TGFβ1 treatment, giving rise to M cells, as previously described in our previous 2D model12,13. Key EMT-associated phenotypic alterations were clearly identified in our 3D model, such as loss of cell-cell adhesions (loss of functional E-cadherin) and expression/deposition of the ECM protein FN and the cytoskeleton protein Vim, indicating a switch towards a mesenchymal-like phenotype. EMT response downstream of TGFβ1 signaling is induced by transcriptional reprogramming, promoting activation of genes encoding mesenchymal proteins such as N-cadherin, which renders cells more motile and invasive, as well as transcriptional factors such as Zeb2, both of which were up-regulated in our 3D model49,50. We also observed a significantly down-regulation in mRNA expression of Mgat3 and Id2 in M cells. Mgat3 encodes for N-acetylglucosaminyltransferase III (GnT-III), which modulates the glycosylation state of E-cadherin in epithelial adherens-junctions, leading to E-cadherin internalization and disruption of cell-cell contacts12,51. We previously showed that Mgat3 expression was dramatically decreased during EMT in 2D, and later recovered when cells partially returned to an epithelial-like phenotype, and identified Mgat3 glycogene and GnT-III mediated glycosylation (specifically on E-cad) as a novel and major component of the EMT mechanism signature. On the other hand, Id2 is a member of the helix-loop-helix (HLH) protein family that has been described as an EMT antagonist, maintaining epithelial differentiation. Strong suppression of Id2 expression has been observed during EMT in different epithelial models, and forcing Id2 expression in mesenchymal cells has been shown to partially rescue an epithelial phenotype32,52,53,54. Therefore, the significant decrease in Mgat3 and Id2 expression, as observed here, further points to the occurrence of EMT in our 3D model.
Removal of TGFβ1 clearly resulted in (partial) EMT reversion, generating what we called RE cells, a hybrid cell population endowed with mixed epithelial and mesenchymal characteristics. Phenotypically, these cells recovered functional E-cad protein expression at cell membrane, however retaining concomitant expression of characteristic mesenchymal proteins (FN and Vim). Importantly, RE cells also displayed an intermediate mRNA expression profile for the genes described above, in particular RE cells displayed a significant up-regulation of the epithelial marker Ocln, while retaining high levels of expression of mesenchymal markers, such as CDH2 and Zeb2. These observations support the intermediate nature of this cellular state12,13.
The phenotypic alterations occurring during EMT and its reversion in 3D reflect different functional properties of E, M and RE cellular states. It has being described that TGFβ1 is not only responsible for EMT induction but also is capable to arrest the mammary epithelial cell cycle55. Growth-arrest is currently considered as one of the hallmarks of EMT, allowing cells to (de)differentiate, acquire a mesenchymal-like phenotype and become motile and invasive56,57. Also, it has been reported that EMT-inducing transcriptional factors can directly inhibit cell proliferation3. In our 3D model, proliferation was in fact decreased in M cells, which also presented higher levels of MMP2 and MMP9 activity, known to play a key role in initiating localized matrix degradation at basement membrane, during epithelial cancer invasion34. On the other hand, it has also been proposed that EMT reversion is a driving force of metastasis, being necessary for the re-acquisition of proliferative activity and colonization capacity56. The RE cells population generated with our 3D model recovered some proliferative activity, as compared to M cells, showing ability to form very large multicellular spheroids, and also displayed slightly higher levels of MMPs activity than E cells. Moreover, E, M and RE cells recovered from 3D culture also exhibited strikingly different behaviors when entrapped in Matrigel. While E cells were able to form structures resembling organotypic mammary acini with apical-basal polarity, M and RE cells formed more disorganized cell spheroids, containing cells with front-back polarity, a feature that has been associated to malignant phenotypes35,36. However, only RE cells showed ability to form very large spheroids, forming complex structures35. This further supports that RE cells obtained in our 3D model present features of intermediate phenotypes, likely containing heterogeneous cell subpopulations with high clonogenic capacity and ability to form large colonies, while maintaining invasive capacity, hallmarks of a more aggressive phenotype.
In summary, in our 3D model we were able to generate a hybrid phenotype of RE cells that clearly shares features from both E and M cells, which has been correlated with a more aggressive behavior. Although capturing EMT transient stages in vivo has been challenging, namely due to current lack of reliable markers and readouts, a few recent studies suggest that cells in hybrid E/M or partial EMT state are effectively most likely to give rise to more aggressive tumor clones, as opposed to cells in pure epithelial (E) or pure mesenchymal (M) states. The 3D-RE cells that we herein generated share features with intermediate or hybrid EMT states observed in vivo, namely: 1) epithelial morphology reminiscent of E cells and invasive features similar to M cells; 2) concomitant expression of epithelial and mesenchymal markers (high CDH1 and Ocl and high CDH2 and Zeb2), and; 3) sustained expression of the E-cadherin repressor Zeb2. These observations support an association with more aggressive phenotypes as described by Strauss et al., who showed that some cells in hybrid E/M phenotype in primary ovarian cultures and tumors in situ can express heterogeneous lineage markers, and drive tumor growth in vivo by giving rise to another E/M subset, as well as completely differentiated epithelial cells58. In another study, Ruscetti et al. isolated hybrid E/M cells in vivo in a prostate cancer mouse model and demonstrated their comparable or even higher tumor-initiating potential as compared to full mesenchymal cells59. Our system thus stands as a valuable 3D in vitro model to generate and investigate cells with metastable phenotypes, which are highly relevant.
The proposed system is highly versatile, as it allows independent tuning of several matrix features, such as adhesiveness, stiffness and degradability, as previously described by our group23,24, which can be used to modulate cell-cell and cell-matrix interactions in a strictly controlled way. This way, in future studies, it may be easily optimized for culturing other relevant cell lines, namely normal and/or cancer human cells. The proposed 3D model is thus expected to provide a valuable tool for mechanistically defining molecular characteristics of invasive cells and their surrounding matrix. This will pave the way for the development of new anti-cancer therapies targeting, for example, the reversion of metastable phenotypes by stabilizing the non-invasive epithelial phenotype60.
Conclusions
A new 3D in vitro platform for generating and tracking intermediate stages of cancer-associated EMT was developed. Soft RGD-alginate matrices supported normal epithelial morphogenesis, while allowing TGFβ1–induced EMT and its reversion, which generated cells with epithelial-like, mesenchymal-like and, most importantly, intermediate phenotypes. The proposed bioengineered matrices provide simple, yet biologically meaningful, cellular microenvironments, where cell-matrix interactions can be precisely modulated in a systematic way. Their use as a 3D in vitro model for studying metastable EMT stages is expected to improve current knowledge towards identification of putative targets for more effective anti-cancer therapies.
Materials and Methods
Synthesis and characterization of RGD-alginate
Ultrapure sodium alginate (PRONOVA UP LVG, Novamatrix, FMC Biopolymers) was covalently grafted with the cell-adhesion peptide (glycine)4-arginine-glycine-aspartic acid-serine-proline (hereafter abbreviated as RGD) using aqueous carbodiimide chemistry as previously described61. Briefly, alginate solutions (1 wt.%) in MES buffer (0.1 M MES, 0.3 M NaCl, pH 6.5) were prepared and stirred overnight (ON) at room temperature (RT). N-Hydroxy-sulfosuccinimide (Sulfo-NHS, Pierce) and 1-ethyl-(dimethylaminopropyl)-carbodiimide (EDC, Sigma, 27.4 mg per g of alginate) were sequentially added at a molar ratio of 1:2, followed by 100 mg of RGD peptide (Genscript) per g of alginate. After stirring for 20 h at RT, the reaction was quenched with hydroxylamine (Sigma) and the solution was dialyzed against deionized water for 3 days (MWCO 3500). After purification with charcoal, RGD-alginate was lyophilized and stored at −20 °C until further use. The reaction yield was calculated using the BCA Protein Assay (Pierce), as previously described in62.
Preparation and characterization of RGD-alginate hydrogel matrices
In situ forming alginate hydrogel matrices were prepared by internal gelation as described previously23,24,62. Hydrogel precursor solution was prepared at 1 wt.% sodium alginate in 0.9 wt.% NaCl, with 200 μM RGD, a density comparable to that present in commonly used ECM-derived biological matrices25. The solution was sterile-filtered (0.22 μm) and mixed with an aqueous suspension of sterile CaCO3 (Fluka) at a CaCO3/COOH molar ratio of 1.662. Then, a fresh sterile solution of glucone delta-lactone (GDL, Sigma) was added to trigger gelation. The CaCO3/GDL molar ratio was set at 0.125, and the gelation time was 45 min.
Rheological measurements were carried out using a Kinexus Pro rheometer (Malvern). Hydrogel discs were analyzed at day 0 (after swelling to equilibrium in culture media for 1 h) with and without cells under standard culture conditions. To guarantee the dimensional homogeneity of the samples, 8 mm cylindrical discs were cast, and then 4 mm cylinders were punched from the original ones immediately before analysis. All samples were assayed using a plate-and-plate geometry (4 mm diameter, sandblasted surfaces) and were compressed to 20% of their original thickness to avoid slippage. A solvent trap was used to minimize sample drying. All measurements were performed at 37 °C (Peltier system). Stress sweeps (0.1 Hz) were first performed to determine the LVR. Frequency sweeps (0.01–2 Hz) were then performed within the LVR. The values of the shear moduli (G’ and G”) and phase angle, were obtained at a frequency of 0.1 Hz. Samples were analyzed in triplicate.
3D culture of EpH4 cells and TGFβ1-driven EMT induction/reversion
EpH4 cell line was kindly provided by Dr. Angela Burleigh and Dr. Calvin Roskelley: from British Columbia Cancer Agency, Vancouver, Canada. EpH4 authentication was performed at the Ipatimup’s Cell Lines Bank, using STR amplification (Promega-Powerplex16, Identifiler). For cell entrapment, EpH4 cells37 (5 × 106 cells/mL) were combined with RGD-alginate solution and crosslinking agents and the mixture was pipetted (20 μL) onto Teflon plates separated by 750 μm-height spacers. For spheroid quantification discs with 8 μL and 250 μm height were made. After gelation, 3D matrices were transferred to pHEMA-treated 24-well culture plates. Thereafter, fresh medium was added and renewed after 1 h. 3D culture of EpH4 (classified as E for epithelial) were maintained in DMEM/F-12 with glutamax (Gibco) supplemented with 5% v/v FBS (Biowest), 1% v/v penicilin/streptomycin (Gibco) and 5 μg/mL insulin solution human (Sigma). To induce EMT in 3D cultured EpH4 cells (Fig. 4b), culture medium was supplemented with 16 ng/mL of TGFβ1 during 7 days to generate mesenchymal-like cells (classified as M for mesenchymal). The culture medium was changed every other day with fresh TGFβ1. To revert the EMT process (Fig. 4b), 3D culture of M cells was maintained in non-supplemented culture medium for another 7 days to generate cells with intermediate phenotype (classified as RE for reversed epithelia). To guarantee that all TGFβ1 was removed from the hydrogel, fresh medium was added, removed after 2–3 hours and replaced with new fresh medium, which was changed every other day.
Viability, proliferation and metabolic activity in 3D
Cell viability was evaluated using the Live/Dead assay. Cell-laden matrices were washed three times with DMEM/F-12 without phenol red (Gibco), then incubated (45 min, 37 °C in the dark) with calcein AM (1 μM, live cells) and ethidium homodimer-1 (EthD-1, 2.5 μM, dead cells) and washed again. Samples were imaged by confocal laser scanning microscopy (CLSM, Leica SP2 AOBS SE).
Cell proliferation was assessed by Ki-67 (Abcam, 1:100) immunostaining. EpH4-laden hydrogels were fixed with 4 wt.% paraformaldehyde (PFA, Sigma) in TBS-Ca (TBS with 7.5 mM CaCl2) for 20 min, permeabilized for 5 min with 0.2% v/v Triton X-100/TBS-Ca, and then incubated for 1 h in 5 wt.% bovine serum albumin (BSA) in TBS-Ca to block unspecific binding. Finally, samples were incubated with goat anti-rabbit secondary antibody Alexa Fluor 488 (Molecular Probes, Invitrogen, 1:1000, 1 h at RT) and nuclei were counterstained with DAPI.
Cell metabolic activity was assessed using the resazurin assay. Cell-laden matrices were incubated with 20% v/v of the stock resazurin solution (0.1 mg/mL, Sigma) in medium for 2 h at 37 °C. The supernatant was then transferred to a 96-well plate black with clear bottom (Greiner) and fluorescence measurements were carried out using a microplate reader (Biotek Synergy MX) with Ex/Em at 530/590 nm. For each condition n = 3 replicates were analyzed from 3 different biological replicas.
For total double-stranded DNA (dsDNA) quantification, the 3D matrices were dissolved and EpH4 cells were recovered by centrifugation (1500 rpm, 5 min) washed with PBS, centrifuged and stored at −20 °C until analyzed. Cells were lysed in 1% v/v Triton X-100 for 1 h at 250 rpm and 4 °C. Samples were then diluted 1:10 in PBS and used for dsDNA quantification using the Quant-iT PicoGreen dsDNA kit (Molecular Probes, Invitrogen), according to manufacturer’s instructions. Briefly, samples were transferred to a 96-well plate black with clear bottom and diluted in TE buffer (200mMTris–HCl, 20 mM EDTA, pH 7.5). After adding the Quant-iT PicoGreen dsDNA reagent, samples were incubated for 5 min at RT in the dark, and fluorescence was quantified using a microplate reader with Ex/Em at 480/520 nm. For each condition n = 3 replicates were analyzed from 3 different biological replicas.
Analysis and quantification of spheroids formation
For analysis of spheroids formation at day 1, 7 and 14, EpH4 cells were pre-labeled with CellTracker Green CMFDA (Molecular Probes) at 15 μM for 30 min, and then entrapped within alginate matrices as described. Whole-mounted samples with fluorescence-labeled cells within alginate matrices were imaged by CLSM. The scanned Z-series were projected onto a single plane and colored using Fiji. For quantification of spheroids number and size during epithelial morphogenesis and EMT and its reversion, EpH4-laden hydrogels at different time points (E cells at day 1, 7 and 14) and at different states (E, M and RE) were fixed, permeabilized and blocked as described above. F-actin filaments were stained with Alexa Fluor 488 phalloidin (Invitrogen, 1:40 in 1 wt.% BSA/TBS-Ca, 1 h at RT) and nuclei were counterstained with DAPI. Samples were imaged by CLSM. The scanned Z-series were projected onto a single plane and spheroid diameter and number was assessed with Fiji. Three independent gels were analyzed for each condition and time point, and a total of 1876 and 1357 spheroids were analyzed for epithelial morphogenesis and EMT and its reversion, respectively.
Histological analysis
For histology, EpH4-laden matrices (E state) at day 12 were dehydrated with a series of ethanol solutions of increasing concentrations and included in paraffin blocks. Thereafter, sections (3 μm) were recovered, de-paraffinized in Clear-RiteTM 3 and rehydrated with a series of ethanol solutions of decreasing concentrations and finally water. For hematoxilin and eosin (H&E) staining, sections were incubated in Gill’s hematoxylin for 3 min and counterstained with Eosin Y for 2 min. Finally sections were dehydrated, de-paraffinized in Clear-RiteTM 3 and mounted in glass slides using Entellan® mounting medium. Samples were imaged by optical microscopy.
Analysis of morphology, polarity, matrix deposition and phenotype
EpH4-laden matrices (E state) at day 12 were fixed, permeabilized and blocked as previously described. To analyze polarity, samples were incubated with the following primary antibodies overnight at 4 °C: rabbit anti-mouse ZO-1 (Invitrogen, 1:50) and goat anti-mouse β-catenin (BD Biosciences, 1:50). Afterwards, samples were incubated with goat anti-rabbit secondary antibody Alexa Fluor 488 and goat anti-mouse Alexa Fluor 594 (Molecular Probes, Invitrogen, 1:1000, 1 h at RT). To analyze the deposition of a laminin-rich layer, samples were incubated with primary rabbit anti-mouse laminin antibody (Sigma, 1:50, overnight at 4 °C) and then with goat anti-rabbit secondary antibody Alexa Fluor 488 (Molecular Probes, Invitrogen, 1:1000, 1 h at RT). In both cases, nuclei were counterstained with DAPI and samples were imaged by CLSM.
EpH4-laden matrices at different states (E, M and RE) were fixed, permeabilized and blocked as described in previous section. Subsequently, samples were incubated with the following primary antibodies: rabbit anti-mouse E-cadherin (Cell Signaling, 1:100, 2 hours at RT); rabbit anti-mouse fibronectin (Sigma, 1:100, ON at 4 °C) and rabbit anti-mouse vimentin (GenScript, 1:100, overnight at 4 °C). Finally, samples were incubated with goat anti-rabbit secondary antibody Alexa Fluor 594 (for E-cadherin) and 488 (for fibronectin and vimentin) (Molecular Probes, Invitrogen, 1:1000, 1 h at RT) and nuclei were counterstained with DAPI. Samples were imaged by CLSM and the scanned Z-series were projected onto a single plane and colored using Fiji. To assess lumen formation images were composed of only 1 Z-stack, which allows visualizing the central part of the spheroids, and thus lumens.
RNA expression quantification
RNA was extracted from EpH4-laden matrices at the three different states (E, M and RE) (n = 4 biological replicas) using the Quick-RNA MiniPrep (Zymo Research), as recommended by the manufacturer. Subsequently, 1000 ng of total RNA were reversed transcribed to single stranded cDNA using Superscript First-strand synthesis synthesis and random hexamer primers (Invitrogen). Quantitative Real-Time PCR (qRT-PCR) was carried out using source RNA from 4 biological replicas for the target genes CDH1, Ocln, CDH2, Zeb2, Mgat3, Id2 and for endogenous control GAPDH using as probe sets Mm00486909, Mm.PT.47.16166845, Mm00483212_m1, Mm.PT.47.13169136, Mm00447798_s1, Mm00711781_m1, 4352932 (Applied Biosystems and Integrated DNA Technologies), respectively. Samples were run in triplicates in the ABI Prism 7000 Sequence Detection System under the following conditions: 95 °C for 20 sec, followed by 40 cycles at 95 °C for 3 sec and 60 °C for 30 sec. Data was analyzed by the comparative 2(−ΔΔCT) method63.
Matrix metalloproteinases (MMPs) secretion by zymography
To detect expression of MMPs (MMP2 and MMP9) activity by 3D cultured cells at different states (E, M and RE), cell culture supernatants were analyzed by gelatin-zymography from 3 biological replicas. After 72 h, conditioned media were collected, centrifuged to remove cell debris and loaded into gelatin-SDS polyacrylamide gels. Sample volumes were adjusted to yield equivalent total cell protein contents, which were quantified by the BCA Protein Assay (Pierce) in lysates of cells recovered from the hydrogels62. The gel was run in 1× Tris-Glycine SDS running buffer at 60 V (Mini Protean Tetra Cell system, BioRad). After electrophoresis, gels were washed twice and subsequently incubated in MMP substrate buffer for 16 h at 37 °C. Afterwards, gels were washed and stained with Coomassie Brilliant Blue R-250 (Sigma). MMPs proteolytic activity was visualized as the presence of clear bands against a blue background of Coomassie Blue-stained gelatin substrate. Thereafter, the gel was washed with distilled water, scanned using the GS-800 Calibrated Densiometer (Bio-Rad) and MMPs activity was estimated by densitometric analysis (Quantity One, Bio-rad).
Evaluation of invasive potential of E, M and RE cells
E, M and RE cells were retrieved from alginate matrices upon dissolution with 0.05% w/v trypsin/50 mM EDTA solution, followed by centrifugation and incubation with collagenase II (1.5 mg/mL) for 30 min to dissociate cell spheroids. After centrifugation, cells were mixed with Matrigel Reduced Growth Factor (Corning) and 20 μL drops were pipetted into each well of a 24 well suspension culture plate (each EpH4-laden alginate gave rise to one EpH4-laden matrigel). After polymerization (30 min at 37 °C), fresh DMEM/F-12 was added to each sample. E and RE-laden matrigel were maintained in standard culture medium, while for M cells medium was supplemented with 16 ng/mL of TGFβ1. After 7 days, cell morphology was visualized under an inverted microscope (Axiovert 200 M, Zeiss). Metabolic activity was measured using the resazurin assay, immediately after entrapment and at day 7. For each condition n = 3 replicates were analyzed.
Statistical analyses
Statistical analyses were performed using GraphPad Prism 6.0 software version 6.0 f. The non-parametric Mann–Whitney test was used to compare two groups. To compare spheroid diameter and number, Unpaired t test was used. Results for all analysis with ‘p’ value less than 0.05 were considered to indicate statistically significant differences (*p ≤ 0.05; **p < 0.01; ***p < 0.001).
Additional Information
How to cite this article: Bidarra, S. J. et al. A 3D in vitro model to explore the inter-conversion between epithelial and mesenchymal states during EMT and its reversion. Sci. Rep. 6, 27072; doi: 10.1038/srep27072 (2016).
References
Tomaskovic-Crook, E., Thompson, E. W. & Thiery, J. P. Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res 11, 213 (2009).
Yang, J. & Weinberg, R. A. Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis. Dev Cell 14, 818–829 (2008).
Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2, 442–454 (2002).
Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J Clinical Invest 119, 1420–1428 (2009).
Brabletz, T. EMT and MET in Metastasis: Where Are the Cancer Stem Cells? Cancer Cell 22, 699–701 (2012).
Ribeiro, A. S. & Paredes, J. P-Cadherin Linking Breast Cancer Stem Cells and Invasion: A Promising Marker to Identify an “Intermediate/Metastable” EMT State. Front Oncol 4, 371 (2015).
Klymkowsky, M. W. & Savagner, P. Epithelial-Mesenchymal Transition: A Cancer Researcher’s Conceptual Friend and Foe. Am J Pathol 174, 1588–1593 (2009).
Schmidt, J. M. et al. Stem-Cell-like Properties and Epithelial Plasticity Arise as Stable Traits after Transient Twist1 Activation. Cell Rep 10, 131–139 (2015).
Chaffer, C. L. & Weinberg, R. A. A Perspective on Cancer Cell Metastasis. Science 331, 1559–1564 (2011).
Krasnapolski, M. A., Todaro, L. B. & de Kier Joffe, E. B., Is the epithelial-to-mesenchymal transition clinically relevant for the cancer patient? Curr Pharm Biotechnol 12, 1891–1899 (2011).
Yu, M. et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition. Science 339, 580–584 (2013).
Pinho, S. S. et al. Loss and Recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation Is a Mechanism Involved in Epithelial-Mesenchymal-Epithelial Transitions. PLoS ONE 7, e33191 (2012).
Olivera, P. et al. Through the looking glass: the reversion of EMT. Eur J Hum Genet 3, Supplement 1 (2015).
Roudsari, L. C. & West, J. L., Studying the influence of angiogenesis in in vitro cancer model systems. Adv Drug Deliv Rev 97, 250–259 (2016).
Pampaloni, F., Reynaud, E. G. & Stelzer, E. H. K. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8, 839–845 (2007).
Lee, G. Y., Kenny, P. A., Lee, E. H. & Bissell, M. J. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 4, 359–365 (2007).
Tibbitt, M. W. & Anseth, K. S. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 103, 655–663 (2009).
Gill, B. J. & West, J. L. Modeling the tumor extracellular matrix: Tissue engineering tools repurposed towards new frontiers in cancer biology. J Biomech 47, 1969–1978 (2014).
Fischbach, C. et al. Engineering tumors with 3D scaffolds. Nat Methods 4, 855–860 (2007).
Zaman, M. H. The role of engineering approaches in analysing cancer invasion and metastasis. Nat Rev Cancer 13, 596–603 (2013).
Marx, V. Tracking metastasis and tricking cancer. Nature 494, 133–138 (2013).
Gill, B. J. et al. A Synthetic Matrix with Independently Tunable Biochemistry and Mechanical Properties to Study Epithelial Morphogenesis and EMT in a Lung Adenocarcinoma Model. Cancer Res 72, 6013–6023 (2012).
Bidarra, S. J. et al. Injectable in situ crosslinkable RGD-modified alginate matrix for endothelial cells delivery. Biomaterials 32, 7897–7904 (2011).
Maia, F. R. et al. Matrix-driven formation of mesenchymal stem cell-extracellular matrix microtissues on soft alginate hydrogels. Acta Biomater 10, 3197–3208 (2014).
Huebsch, N. et al. Harnessing Traction-Mediated Manipulation of the Cell-Matrix Interface to Control Stem Cell Fate. Nat Mater 9, 518–526 (2010).
Butcher, D. T., Alliston, T. & Weaver, V. M. A tense situation: forcing tumour progression. Nat Rev Cancer 9, 108–122 (2009).
Paszek, M. J. et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241–254 (2005).
Levental, K. R. et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin signaling. Cell 139, 891–906 (2009).
Weiss, M. S. et al. The impact of adhesion peptides within hydrogels on the phenotype and signaling of normal and cancerous mammary epithelial cells. Biomaterials 33, 3548–3559 (2012).
Mi, K. & Xing, Z. CD44(+)/CD24(−) breast cancer cells exhibit phenotypic reversion in three-dimensional self-assembling peptide RADA16 nanofiber scaffold. Int J Nanomedicine 10, 3043–3053 (2015).
Li, S. et al. Cell Surface Glycan Alterations in Epithelial Mesenchymal Transition Process of Huh7 Hepatocellular Carcinoma Cell. PLoS ONE 8, e71273 (2013).
Kowanetz, M. et al. Id2 and Id3 Define the Potency of Cell Proliferation and Differentiation Responses to Transforming Growth Factor beta and Bone Morphogenetic Protein. Mol Cell Biol 24, 4241–4254 (2004).
Radisky, E. S. & Radisky, D. C. Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer. J Mammary Gland Biol Neoplasia 15, 201–212 (2010).
Jacob, A. & Prekeris, R. The regulation of MMP targeting to invadopodia during cancer metastasis. Front Cell Dev Biol 3, 4 (2015).
Kenny, P. A. et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 1, 84–96 (2007).
Benton, G., Kleinman, H. K., George, J. & Arnaoutova, I. Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells. Int J Cancer 128, 1751–7 (2011).
Montesano, R., Soriano, J. V., Fialka, I. & Orci, L. Isolation of EpH4 mammary epithelial cell subpopulations which differ in their morphogenetic properties. In Vitro Cell Dev Biol Anim 34, 468–477 (1998).
Lu, M. et al. MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination. Proc Nati Acad Sci USA 110, 18144–18149 (2013).
Chaffer, C. L. et al. Mesenchymal-to-Epithelial Transition Facilitates Bladder Cancer Metastasis: Role of Fibroblast Growth Factor Receptor-2. Cancer Res 66, 11271–11278 (2006).
Korpal, M. et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med 17, 1101–1108 (2012).
Boontheekul, T., Kong, H.-J. & Mooney, D. J. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials 26, 2455–2465 (2005).
Lee, K. et al. Matrix compliance regulates Rac1b localization, NADPH oxidase assembly, and epithelial-mesenchymal transition. Mol Biol Cell 23, 4097–4108 (2012).
Wei, S. C. et al. Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. Nat Cell Biol 17, 678–688 (2015).
Aguirre, A., Planell, J. A. & Engel, E. Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis. Biochem Biophys Res Commun 400, 284–291 (2010).
McCaffrey, L. M. & Macara, I. G. Epithelial organization, cell polarity and tumorigenesis. Trends Cell Biol 21, 727–735 (2011).
Chaudhuri, O. et al. Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium. Nat Mater 13, 970–978 (2014).
Provenzano, P. P., Inman, D. R., Eliceiri, K. W. & Keely, P. J. Matrix density-induced mechanoregulation of breast cell phenotype, signaling, and gene expression through a FAK-ERK linkage. Oncogene 28, 4326–4343 (2009).
Foroni, L. et al. The role of 3D microenvironmental organization in MCF-7 epithelial-mesenchymal transition after 7 culture days. Exp Cell Res 319, 1515–1522 (2013).
Pang, M. F. et al. TGF-[beta]1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis. Oncogene 35, 748–760 (2016).
Xu, J., Lamouille, S. & Derynck, R. TGF-[beta]-induced epithelial to mesenchymal transition. Cell Res 19, 156–172 (2009).
Xu, Q. et al. Roles of N-Acetylglucosaminyltransferase III in Epithelial-to-Mesenchymal Transition Induced by Transforming Growth Factor beta1 (TGF-beta1) in Epithelial Cell Lines. J Biol Chem 287, 16563–16574 (2012).
Kondo, M. et al. A role for Id in the regulation of TGF-[beta]-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ 11, 1092–1101 (2004).
Chang, C., Yang, X., Pursell, B. & Mercurio, A. M. Id2 Complexes with the SNAG Domain of Snai1 Inhibiting Snai1-Mediated Repression of Integrin beta4. Mol Cell Biol 33, 3795–3804 (2012).
Zavadil, J. & Bottinger, E. P. TGF-[beta] and epithelial-to-mesenchymal transitions. Oncogene 24, 5764–5774 (2005).
Tan, E. J., Olsson, A.-K. & Moustakas, A. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ. Cell Adh Migr 9, 233–246 (2015).
Brabletz, T. et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Nati Acad Sci USA 98, 10356–10361 (2001).
Tran, D. D. et al. Temporal and Spatial Cooperation of Snail1 and Twist1 during Epithelial-Mesenchymal Transition Predicts for Human Breast Cancer Recurrence. Mol Cancer Res 9, 1644–1657 (2011).
Strauss, R. et al. Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity. PLoS ONE 6, e16186 (2011).
Ruscetti, M. et al. Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. Cancer Res 75, 2749–2759 (2015).
Jordan, N. V., Johnson, G. L. & Abell, A. N. Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell Cycle 10, 2865–2873 (2011).
Rowley, J. A., Madlambayan, G. & Mooney, D. J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20, 45–53 (1999).
Fonseca, K. et al. Molecularly-designed alginate hydrogels susceptible to local proteolysis as 3D cellular microenvironments. Acta Biomater 7, 1674–1682 (2011).
Livak, K. J. & Schmittgen, T. D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-[Delta][Delta]CT Method. Methods 25, 402–408 (2001).
Acknowledgements
IPATIMUP and INEB integrate the i3S Research Unit, which is partially supported by FCT, the Portuguese Foundation for Science and Technology. This work was funded by: 1) FCT/MEC through National Funds and, when applicable, co-financed by the FEDER via the PT2020 Partnership Agreement under the 4293 Unit I&D.; 2) FEDER funds through the Operational Programme for Competitiveness Factors - COMPETE and National Funds through the FCT and under the projects “PEst-C/SAU/LA0003/2013” and FCT/MEC through National Funds and co-financed by the FEDER through the PT2020 Partnership Agreement under the project no. 007274 (UID/BIM/04293); 3) NORTE-07-0162-FEDER-000118 -Contributos para o reforço da capacidade do IPATIMUP enquanto actor do sistema regional de inovação” and NORTE-07-0162-FEDER-000067 - Reforço e consolidação da capacidade infraestrutural do IPATIMUP para o sistema regional de inovação”, both supported by Programa Operacional Regional do Norte (ON.2 – O Novo Norte), through FEDER funds under the Quadro de Referência Estratégico Nacional (QREN); 4) FCT Fellowships SFRH/BPD/80571/2011 to SJB and SFRH/BPD/89764/2012 to PO and PD/BI/113971/2015 to SR; 5) Research position (IF, Investigator FCT) funded by FCT and POPH/ESF (EC) to CCB; 6) Projected funded by POCI via FEDER (POCI-01-0145-FEDER-016627) and by FCT via OE (PTDC/BBB-ECT/2518/2014). The authors are grateful to Dra Joana Paredes (i3S/IPATIMUP) for providing the H&E stained normal breast tissue samples.
Author information
Authors and Affiliations
Contributions
S.J.B. designed experiments, acquired and analyzed the data and wrote the manuscript, P.O. and S.R. designed experiments, acquired and analyzed the data, D.P.S. acquired the data, C.O. and C.C.B. designed and supervised the whole work, analyzed the data and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Bidarra, S., Oliveira, P., Rocha, S. et al. A 3D in vitro model to explore the inter-conversion between epithelial and mesenchymal states during EMT and its reversion. Sci Rep 6, 27072 (2016). https://doi.org/10.1038/srep27072
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep27072
- Springer Nature Limited
This article is cited by
-
An in vitro culture platform for studying the effect of collective cell migration on spatial self-organization within induced pluripotent stem cell colonies
Journal of Biological Engineering (2023)
-
The epithelial-mesenchymal transition and the cytoskeleton in bioengineered systems
Cell Communication and Signaling (2021)
-
3-D vascularized breast cancer model to study the role of osteoblast in formation of a pre-metastatic niche
Scientific Reports (2021)
-
Advancing Cell-Instructive Biomaterials Through Increased Understanding of Cell Receptor Spacing and Material Surface Functionalization
Regenerative Engineering and Translational Medicine (2021)
-
A Novel 3-Dimensional Co-culture Method Reveals a Partial Mesenchymal to Epithelial Transition in Breast Cancer Cells Induced by Adipocytes
Journal of Mammary Gland Biology and Neoplasia (2019)